These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9501184)
21. N-containing sugars from Morus alba and their glycosidase inhibitory activities. Asano N; Oseki K; Tomioka E; Kizu H; Matsui K Carbohydr Res; 1994 Jun; 259(2):243-55. PubMed ID: 8050098 [TBL] [Abstract][Full Text] [Related]
22. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510 [TBL] [Abstract][Full Text] [Related]
23. Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors. Kato A; Hirokami Y; Kinami K; Tsuji Y; Miyawaki S; Adachi I; Hollinshead J; Nash RJ; Kiappes JL; Zitzmann N; Cha JK; Molyneux RJ; Fleet GW; Asano N Phytochemistry; 2015 Mar; 111():124-31. PubMed ID: 25583438 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of (+)- and (-)-nojirimycin and their 1-deoxy derivatives from myo-inositol. Chida N; Furuno Y; Ikemoto H; Ogawa S Carbohydr Res; 1992 Dec; 237():185-94. PubMed ID: 1294293 [TBL] [Abstract][Full Text] [Related]
25. Paenibacillus sp. TS12 glucosylceramidase: kinetic studies of a novel sub-family of family 3 glycosidases and identification of the catalytic residues. Paal K; Ito M; Withers SG Biochem J; 2004 Feb; 378(Pt 1):141-9. PubMed ID: 14561218 [TBL] [Abstract][Full Text] [Related]
26. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis. Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, self-assembly behaviours and multivalent glycosidase inhibition effects of a deoxynojirimycin modified perylene bisimide derivative. Li JJ; Wang KR; Li RF; Yang JX; Li M; Zhang HX; Cao ZR; Li XL J Mater Chem B; 2019 Feb; 7(8):1270-1275. PubMed ID: 32255166 [TBL] [Abstract][Full Text] [Related]
28. An approach to sequence-specific antibody proteases. The use of haptens mimicking both a transition state and a distorted ground state. Smith RM; Yuan P; Weiner DP; Dutton CR; Hansen DE Appl Biochem Biotechnol; 1994; 47(2-3):329-42; discussion 342-3. PubMed ID: 7944347 [TBL] [Abstract][Full Text] [Related]
29. Antibody catalysis of peptidyl-prolyl cis-trans isomerization in the folding of RNase T1. Ma L; Hsieh-Wilson LC; Schultz PG Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7251-6. PubMed ID: 9636134 [TBL] [Abstract][Full Text] [Related]
30. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution. Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565 [TBL] [Abstract][Full Text] [Related]
31. Aspects of antibody-catalyzed primary amide hydrolysis. Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343 [TBL] [Abstract][Full Text] [Related]
32. 1-Aza-sugars from D-glucose. Preparation of 1-deoxy-5-dehydroxymethyl-nojirimycin, its analogues and evaluation of glycosidase inhibitory activity. Patil NT; John S; Sabharwal SG; Dhavale DD Bioorg Med Chem; 2002 Jul; 10(7):2155-60. PubMed ID: 11983511 [TBL] [Abstract][Full Text] [Related]
33. Structural basis for antibody catalysis of a disfavored ring closure reaction. Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817 [TBL] [Abstract][Full Text] [Related]
34. Asymmetric synthesis of the L-fuco-nojirimycin, a nanomolar alpha-L-fucosidase inhibitor. Dubernet M; Defoin A; Tarnus C Bioorg Med Chem Lett; 2006 Mar; 16(5):1172-4. PubMed ID: 16376079 [TBL] [Abstract][Full Text] [Related]
35. Glycoside Hydrolases Restrict the Side Chain Conformation of Their Substrates To Gain Additional Transition State Stabilization. Quirke JCK; Crich D J Am Chem Soc; 2020 Oct; 142(40):16965-16973. PubMed ID: 32877175 [TBL] [Abstract][Full Text] [Related]
36. The elicitation of carboxylesterase activity in antibodies by reactive immunization with labile organophosphorus antigens: a role for flexibility. Schowen RL J Immunol Methods; 2002 Nov; 269(1-2):59-65. PubMed ID: 12379352 [TBL] [Abstract][Full Text] [Related]
37. Supramolecular azasugar clusters based on an amphiphilic fatty-acid-deoxynojirimycin derivative as multivalent glycosidase inhibitors. Li M; Wang KR; Yang JX; Peng YT; Liu YX; Zhang HX; Li XL J Mater Chem B; 2019 Mar; 7(9):1379-1383. PubMed ID: 32255008 [TBL] [Abstract][Full Text] [Related]
38. First total synthesis of 1-O-beta-D-glucopyranosyl-5-deoxyadenophorine and its aglycon congener: determination of the absolute configuration. Felpin FX; Boubekeur K; Lebreton J J Org Chem; 2004 Mar; 69(5):1497-503. PubMed ID: 14987003 [TBL] [Abstract][Full Text] [Related]
39. Comparison of antibody and albumin catalyzed hydrolysis of steroidal p-nitrophenylcarbonates. Riva S; Mendozza M; Carrea G; Chattopadhyay P; Tramontano A Appl Biochem Biotechnol; 1998 Oct; 75(1):33-44. PubMed ID: 10214695 [TBL] [Abstract][Full Text] [Related]
40. Four orders of magnitude rate increase in artificial enzyme-catalyzed aryl glycoside hydrolysis. Ortega-Caballero F; Bjerre J; Laustsen LS; Bols M J Org Chem; 2005 Sep; 70(18):7217-26. PubMed ID: 16122240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]